We are live on ! Find out more
BCM

BTR Capital Management Portfolio holdings

AUM $641M
1-Year Est. Return 9.05%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
-9.05%
3 Year Est. Return
+35.04%
5 Year Est. Return
+68.26%
10 Year Est. Return
AUM
$490M
AUM Growth
+$3M
Cap. Flow
-$10.2M
Cap. Flow %
-2.09%
Top 10 Hldgs %
29.64%
Holding
152
New
2
Increased
19
Reduced
79
Closed
4

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$1.1M
2
CCI icon
Crown Castle
CCI
+$314K
3
CVX icon
Chevron
CVX
+$287K
4
PCG icon
PG&E
PCG
+$270K
5
CVS icon
CVS Health
CVS
+$226K

Top Sells

Rank Stock Value
1
CPN
Calpine Corporation
CPN
+$3.05M
2
DD
Du Pont De Nemours E I
DD
+$1.02M
3
MET icon
MetLife
MET
+$976K
4
AAPL icon
Apple
AAPL
+$952K
5
SJM icon
J.M. Smucker
SJM
+$580K

Sector Composition

Rank Sector Weight
1 Healthcare 14.07%
2 Technology 12.03%
3 Industrials 11.65%
4 Financials 11.43%
5 Energy 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$19.1M 3.9%
496,848
-24,548
-5% -$952K
MSFT icon
2
Microsoft
MSFT
$2.84T
$17.1M 3.49%
229,899
-3,202
-1% -$234K
JPM icon
3
JPMorgan Chase
JPM
$939B
$16.4M 3.35%
172,170
-2,383
-1% -$220K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$3.91T
$15.4M 3.14%
316,740
-2,740
-0.9% -$130K
CVX icon
5
Chevron
CVX
$388B
$14.2M 2.89%
120,728
+2,632
+2% +$287K
PEP icon
6
PepsiCo
PEP
$186B
$12.8M 2.61%
115,056
-1,158
-1% -$134K
TMO icon
7
Thermo Fisher Scientific
TMO
$211B
$12.8M 2.61%
67,745
-827
-1% -$150K
V icon
8
Visa
V
$677B
$12.6M 2.57%
119,707
-1,685
-1% -$171K
AWK icon
9
American Water Works
AWK
$26.3B
$12.5M 2.55%
154,273
-812
-0.5% -$65.7K
JNJ icon
10
Johnson & Johnson
JNJ
$635B
$12.3M 2.51%
94,737
-1,265
-1% -$168K
CVS icon
11
CVS Health
CVS
$137B
$12.1M 2.46%
148,440
+2,860
+2% +$226K
DIS icon
12
Walt Disney
DIS
$165B
$11.2M 2.29%
113,880
+345
+0.3% +$35.5K
AL
13
DELISTED
Air Lease Corp
AL
$10.6M 2.16%
248,381
-2,701
-1% -$108K
LOW icon
14
Lowe's Companies
LOW
$116B
$10.6M 2.16%
132,211
-695
-0.5% -$53.2K
ORCL icon
15
Oracle
ORCL
$331B
$10.6M 2.15%
218,473
-2,487
-1% -$124K
HACK icon
16
Amplify Cybersecurity ETF
HACK
$2.63B
$10.4M 2.12%
345,066
-1,365
-0.4% -$40.6K
RTX icon
17
RTX Corp
RTX
$287B
$10.3M 2.11%
141,642
-516
-0.4% -$38.2K
CCI icon
18
Crown Castle
CCI
$32.7B
$9.59M 1.96%
95,920
+3,070
+3% +$314K
PFE icon
19
Pfizer
PFE
$140B
$9.14M 1.86%
269,887
-1,813
-0.7% -$58.3K
XBI icon
20
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$9.12M 1.86%
105,388
-60
-0.1% -$4.81K
MET icon
21
MetLife
MET
$61B
$8.85M 1.81%
170,412
-20,050
-11% -$976K
IHI icon
22
iShares US Medical Devices ETF
IHI
$3.02B
$8.81M 1.8%
316,464
-6,156
-2% -$170K
QCOM icon
23
Qualcomm
QCOM
$176B
$8.71M 1.78%
167,971
-1,470
-0.9% -$77.8K
SLB icon
24
SLB Ltd
SLB
$77.8B
$8.4M 1.71%
120,375
+517
+0.4% +$34.2K
KMI icon
25
Kinder Morgan
KMI
$73.1B
$8.21M 1.67%
428,198
-2,024
-0.5% -$39.4K

Similar funds

BTR Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, BTR Capital Management held 152 positions worth $490M, up 0.62% from $487M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 3.9%. BTR Capital Management opened 2 new positions and exited 4, leaving the 152-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

  • BTR Capital Management's largest Q3 2017 buy was DuPont de Nemours: 6,565 shares worth $1.15M.
  • BTR Capital Management added most to Crown Castle in Q3 2017, an estimated $314K increase.
  • BTR Capital Management's biggest Q3 2017 reduction was MetLife, cutting an estimated $976K.
  • BTR Capital Management fully exited Calpine Corporation in Q3 2017, selling an estimated $3.05M.
  • BTR Capital Management's ten largest holdings make up 30% of its $490M portfolio in Q3 2017.
  • BTR Capital Management opened 2 new positions and closed 4 in Q3 2017.
  • BTR Capital Management's portfolio value rose 0.62% quarter-over-quarter to $490M.

Based on BTR Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.